Viewing StudyNCT00070018

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00070018
Status: COMPLETED
Last Update Posted: 2022-01-11
First Post: 2003-10-03
Brief Title: S0313 Cyclophosphamide Doxorubicin Vincristine Prednisone and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkins Lymphoma
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
noncontiguous stage II mantle cell lymphoma View
stage I mantle cell lymphoma View
stage I adult diffuse large cell lymphoma View
stage I adult Burkitt lymphoma View
anaplastic large cell lymphoma View
contiguous stage II adult diffuse large cell lymphoma View
contiguous stage II adult Burkitt lymphoma View
contiguous stage II mantle cell lymphoma View
noncontiguous stage II adult diffuse large cell lymphoma View
noncontiguous stage II adult Burkitt lymphoma View